IceCure Medical Overview
- Year Founded
-
2006

- Status
-
Public
- Employees
-
64

- Stock Symbol
-
ICCM

- Share Price
-
$1.26
- (As of Friday Closing)
IceCure Medical General Information
Description
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
Contact Information
Website
www.icecure-medical.comCorporate Office
- PO Box 3163
- 7 HaEshel Street
- Caesarea 38900
- Israel
Corporate Office
- PO Box 3163
- 7 HaEshel Street
- Caesarea 38900
- Israel
IceCure Medical Stock Performance
As of 21-Mar-2025, IceCure Medical’s stock price is $1.26. Its current market cap is $70.7M with 56.6M shares.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$1.26 | $1.25 | $0.48 - $1.66 | $70.7M | 56.6M | 369K | -$0.28 |
IceCure Medical Financials Summary
As of 30-Sep-2024, IceCure Medical has a trailing 12-month revenue of $3.67M.
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | 20,267 | 45,611 | 55,446 | 104,255 |
Revenue | 3,671 | 3,229 | 3,085 | 4,138 |
EBITDA | (14,253) | (15,253) | (16,491) | (9,597) |
Net Income | (13,834) | (14,652) | (16,978) | (9,895) |
Total Assets | 15,278 | 16,410 | 30,188 | 32,281 |
Total Debt | 486 | 599 | 597 | 909 |
IceCure Medical Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
IceCure Medical Comparisons
Industry
Financing
Details
IceCure Medical Competitors (12)
One of IceCure Medical’s 12 competitors is Angiodynamics, a Private Debt Financed company based in Latham, NY.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Angiodynamics | Private Debt Financed | Latham, NY | ||||
Orbital Therapy | Corporation | Bedford, MA | ||||
Hygea Medical | Venture Capital-Backed | Beijing, China | ||||
Novian Health | Venture Capital-Backed | Chicago, IL | ||||
CPSI Biotech | Corporation | Owego, NY |
IceCure Medical Patents
IceCure Medical Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4520281-A1 | Cryoprobe | Pending | 11-Sep-2023 | ||
US-20250082384-A1 | Cryoprobe | Pending | 11-Sep-2023 | ||
EP-4309604-A1 | Cryogenic system connector | Pending | 18-Jul-2022 | ||
US-20240019058-A1 | Cryogenic system connector | Active | 18-Jul-2022 | ||
JP-2024012270-A | Low temperature system connector | Active | 18-Jul-2022 | A61B18/02 |
IceCure Medical Signals
IceCure Medical Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
IceCure Medical FAQs
-
When was IceCure Medical founded?
IceCure Medical was founded in 2006.
-
Where is IceCure Medical headquartered?
IceCure Medical is headquartered in Caesarea, Israel.
-
What is the size of IceCure Medical?
IceCure Medical has 64 total employees.
-
What industry is IceCure Medical in?
IceCure Medical’s primary industry is Other Devices and Supplies.
-
Is IceCure Medical a private or public company?
IceCure Medical is a Public company.
-
What is IceCure Medical’s stock symbol?
The ticker symbol for IceCure Medical is ICCM.
-
What is the current stock price of IceCure Medical?
As of 21-Mar-2025 the stock price of IceCure Medical is $1.26.
-
What is the current market cap of IceCure Medical?
The current market capitalization of IceCure Medical is $70.7M.
-
What is IceCure Medical’s current revenue?
The trailing twelve month revenue for IceCure Medical is $3.67M.
-
Who are IceCure Medical’s competitors?
Angiodynamics, Orbital Therapy, Hygea Medical, Novian Health, and CPSI Biotech are some of the 12 competitors of IceCure Medical.
-
What is IceCure Medical’s annual earnings per share (EPS)?
IceCure Medical’s EPS for 12 months was -$0.28.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »